ZURA (Zura Bio Limited) חוב לטווח קצר להון

The price action of Zura Bio Limited (ZURA) securities on the GURU.Markets platform demonstrates the 0.00 indicator. Zura Bio Limited (ZURA) focuses on antibody development, currently generating no revenue and relying on external investments. The business is building a closed drug development environment, securing proprietary rights to therapy methods. Asset value remains independent of economic cycles and is determined exclusively by the outcomes of medical trials.

The ratio is calculated as the proportion of liabilities with a maturity of up to one year to total equity. This metric determines the business's degree of dependence on short-term borrowing and the risk of insolvency. For Zura Bio Limited (ZURA), debt control is critical when financing the environmental modernization of laboratories and implementing filtration systems. Analysis of the short-term debt-to-equity chart allows for an assessment of the company's resilience to financial shocks.